Evidence map›Paper›PMID 42801562›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Extracellular Vesicle Packaged TDP43 Derived From ECs Exacerbates Cigarette Tar-Related Atherosclerosis Progression via Enhancing Macrophage Extracellular Traps.

Xinxin Zhu, Yuwu Chen, Wei Meng, Biyi Xu, Junke Mou, Xiaolin Liu, Mengyang Wang, Qishuo Gu, Qianhui Sun, Man Li and 11 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Xinxin Zhu *Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Yuwu Chen *Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.ORCID https://orcid.org/0009-0001-2156-6965
Wei MengDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Biyi Xu *Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Junke Mou *Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Xiaolin Liu *Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.ORCID https://orcid.org/0009-0006-5663-352X
Mengyang WangDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Qishuo GuDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Qianhui SunDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Man LiDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Chen ZhaoDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.ORCID https://orcid.org/0000-0002-6753-7000
Ming ZengDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Ying LvDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Boling YiDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Sheng QuDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Xiaoxuan BaiDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Ji LiDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Xing LuoDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Sining HuDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Bo YuDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.
Haibo JiaDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin, P. R. China.ORCID https://orcid.org/0009-0006-1770-513X

Funding

China Postdoctoral Science Foundation 2025M772156Harbin Medical University Graduate Research and Innovation Fund YJSCX2024-38HYDHeilongjiang Graduate Excellence Funding Program LJYXL2024-018Key Laboratory of Myocardial Ischemia Open Research Project KF202313National Key R&D Program of China 2023YFC3043504National Natural Science Foundation of China 820720031National Natural Science Foundation of China 82370464National Natural Science Foundation of China 82425030National Natural Science Foundation of China 82470341National Natural Science Foundation of China 82500554National Natural Science Foundation of China U24A20648Natural Science Foundation of Heilongjiang Province JJ2026BS0173Postdoctoral Innovation Talent Support Program BX20250260Postdoctoral Research Funding of Heilongjiang Province LBH-Z24219
6 · The paper itself

Abstract

Smoking acts as a critical risk factor for atherosclerosis (AS), but the precise molecular mechanisms remain unclear. We performed in vivo experiments with TAR-injected ApoE

Indexed as

atherosclerosismacrophage extracellular trapsMAMssmokeTDP43

Identifiers

PMID42801562
PMCPMC13616328

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.